• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1996 年和 2007 年荷兰乙型肝炎病毒感染的流行情况。

Prevalence of hepatitis B virus infection in The Netherlands in 1996 and 2007.

机构信息

Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.

出版信息

Epidemiol Infect. 2012 Aug;140(8):1469-80. doi: 10.1017/S095026881100224X. Epub 2011 Nov 14.

DOI:10.1017/S095026881100224X
PMID:22078095
Abstract

We aimed to assess differences in the prevalence of hepatitis B virus (HBV) infection in The Netherlands between 1996 and 2007, and to identify risk factors for HBV infection in 2007. Representative samples of the Dutch population in 1996 and 2007 were tested for antibodies to hepatitis B core antigen (anti-HBc), hepatitis B surface antigen (HBsAg) and HBV-DNA. In 2007, the weighted anti-HBc prevalence was 3·5% (95% CI 2·2-5·5) and the HBsAg prevalence was 0·2% (95% CI 0·1-0·4). In indigenous Dutch participants, the anti-HBc prevalence was lower in 2007 than in 1996 (P=0·06). First-generation migrants (FGMs) had a 13-fold greater risk of being HBsAg- and/or HBV-DNA-positive than indigenous Dutch participants. In indigenous Dutch participants, risk factors for anti-HBc positivity were older age and having received a blood product before 1990. In FGMs, being of Asian origin was a risk factor. In second-generation migrants, having a foreign-born partner and injecting drug use were risk factors. FGMs are the main target group for secondary HBV prevention in The Netherlands.

摘要

我们旨在评估 1996 年至 2007 年期间荷兰乙型肝炎病毒(HBV)感染的流行率差异,并确定 2007 年 HBV 感染的危险因素。1996 年和 2007 年,对荷兰代表性人群样本进行了乙型肝炎核心抗原(抗-HBc)、乙型肝炎表面抗原(HBsAg)和 HBV-DNA 抗体检测。2007 年,加权抗-HBc 流行率为 3.5%(95%CI 2.2-5.5),HBsAg 流行率为 0.2%(95%CI 0.1-0.4)。在土生土长的荷兰参与者中,2007 年的抗-HBc 流行率低于 1996 年(P=0.06)。第一代移民(FGMs)HBsAg 和/或 HBV-DNA 阳性的风险比土生土长的荷兰参与者高 13 倍。在土生土长的荷兰参与者中,抗-HBc 阳性的危险因素是年龄较大和 1990 年前接受过血液制品。在 FGMs 中,亚洲血统是一个危险因素。在第二代移民中,有外国出生的伴侣和注射吸毒是危险因素。FGMs 是荷兰二级 HBV 预防的主要目标人群。

相似文献

1
Prevalence of hepatitis B virus infection in The Netherlands in 1996 and 2007.1996 年和 2007 年荷兰乙型肝炎病毒感染的流行情况。
Epidemiol Infect. 2012 Aug;140(8):1469-80. doi: 10.1017/S095026881100224X. Epub 2011 Nov 14.
2
High impact of migration on the prevalence of chronic hepatitis B in the Netherlands.移民对荷兰慢性乙型肝炎患病率有重大影响。
Eur J Gastroenterol Hepatol. 2008 Dec;20(12):1214-25. doi: 10.1097/MEG.0b013e32830e289e.
3
De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.在供体人群中抗-HBc阳性率较高的地区,接受来自乙肝核心抗体阳性供体的肝移植后发生的新发乙型肝炎。
Liver Transpl. 2001 Jan;7(1):51-8. doi: 10.1053/jlts.2001.20786.
4
The prevalence and risk factors of hepatitis B virus infection in an adult population in Romania: a nationwide survey.罗马尼亚成年人中乙型肝炎病毒感染的流行情况和危险因素:一项全国性调查。
Eur J Gastroenterol Hepatol. 2013 Jan;25(1):56-64. doi: 10.1097/MEG.0b013e328358b0bb.
5
Prevalence of hepatitis B virus markers among blood donors in a tertiary hospital in Tabuk, northwestern Saudi Arabia.沙特阿拉伯西北部塔布克一家三级医院献血者中乙肝病毒标志物的流行情况。
Int J Infect Dis. 2008 Sep;12(5):495-9. doi: 10.1016/j.ijid.2008.01.010. Epub 2008 Apr 8.
6
Seroprevalence of chronic hepatitis B virus infection among taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination.全民乙肝疫苗接种时代台湾地区1型人类免疫缺陷病毒阳性人群中慢性乙肝病毒感染的血清流行率
Am J Gastroenterol. 2009 Apr;104(4):877-84. doi: 10.1038/ajg.2008.159. Epub 2009 Mar 3.
7
Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study.伊朗哈马丹省乙型肝炎、丁型肝炎和人类免疫缺陷病毒感染的血清流行病学:一项基于人群的研究。
J Trop Med Hyg. 1993 Oct;96(5):277-87.
8
Factors associated with isolated anti-hepatitis B core antibody in HIV-positive patients: impact of compromised immunity.与 HIV 阳性患者乙型肝炎核心抗体单项阳性相关的因素:免疫受损的影响。
J Viral Hepat. 2010 Aug;17(8):578-87. doi: 10.1111/j.1365-2893.2009.01212.x. Epub 2009 Oct 8.
9
Impact of routine hepatitis B immunization on the prevalence of chronic hepatitis B virus infection in the marshall islands and the federated States of micronesia.在马绍尔群岛和密克罗尼西亚联邦,常规乙型肝炎免疫接种对慢性乙型肝炎病毒感染流行率的影响。
Pediatr Infect Dis J. 2010 Jan;29(1):18-22. doi: 10.1097/INF.0b013e3181b20e93.
10
Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.巴基斯坦献血者中的抗乙型肝炎核心抗原检测、病毒标志物及隐匿性乙型肝炎病毒感染:对输血实践的影响
Transfusion. 2007 Jan;47(1):74-9. doi: 10.1111/j.1537-2995.2007.01066.x.

引用本文的文献

1
Hepatitis B infection and immunity in migrant children and pregnant persons in Europe: a systematic review and meta-analysis.欧洲移民儿童和孕妇中的乙型肝炎感染和免疫:系统评价和荟萃分析。
J Travel Med. 2024 Aug 3;31(6). doi: 10.1093/jtm/taae094.
2
The liver in Greco-Arabic and Islamic medicine.希腊-阿拉伯医学和伊斯兰医学中的肝脏。
Clin Liver Dis (Hoboken). 2024 Apr 4;23(1):e0137. doi: 10.1097/CLD.0000000000000137. eCollection 2024 Jan-Jun.
3
Cascade of care among hepatitis B patients in Maastricht, the Netherlands, 1996 to 2018.
1996年至2018年荷兰马斯特里赫特乙肝患者的连续医疗服务情况
J Virus Erad. 2022 Jun 20;8(2):100075. doi: 10.1016/j.jve.2022.100075. eCollection 2022 Jun.
4
Timing of primary three-dose hepatitis B vaccination and postvaccination serologic testing among a large cohort of healthy adults.大量健康成年人中,乙肝三剂初种疫苗的接种时机与接种后血清学检测。
J Med Virol. 2022 Sep;94(9):4433-4439. doi: 10.1002/jmv.27848. Epub 2022 May 17.
5
[Hepatitis B virus infection and vaccine-induced immunity: the role of sociodemographic determinants : Results of the study "German Health Interview and Examination Survey for Adults" (DEGS1, 2008-2011)].[乙型肝炎病毒感染与疫苗诱导的免疫:社会人口学决定因素的作用:“德国成人健康访谈与检查调查”(DEGS1,2008 - 2011年)研究结果]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2022 Feb;65(2):159-169. doi: 10.1007/s00103-021-03473-z. Epub 2021 Dec 27.
6
Clinical practice of hepatitis B screening in patients starting with chemotherapy: A survey among Dutch oncologists.开始化疗的患者乙型肝炎筛查的临床实践:荷兰肿瘤学家的一项调查。
Eur J Cancer Care (Engl). 2021 Nov;30(6):e13495. doi: 10.1111/ecc.13495. Epub 2021 Jul 26.
7
The burden of liver cirrhosis and underlying etiologies: results from the global burden of disease study 2017.肝硬化及其潜在病因的负担:来自 2017 年全球疾病负担研究的结果。
Aging (Albany NY). 2021 Jan 12;13(1):279-300. doi: 10.18632/aging.104127.
8
Clustering of chronic hepatitis B screening intentions in social networks of Moroccan immigrants in the Netherlands.慢性乙型肝炎筛查意愿在荷兰摩洛哥移民社交网络中的聚集现象。
BMC Public Health. 2020 Mar 17;20(1):344. doi: 10.1186/s12889-020-8438-x.
9
Chronic hepatitis B and C infections in the Netherlands: estimated prevalence in risk groups and the general population.荷兰的慢性乙型肝炎和丙型肝炎感染:风险人群和一般人群中的估计患病率。
Epidemiol Infect. 2019 Jan;147:e147. doi: 10.1017/S0950268819000359.
10
Genetic variation of hepatitis B surface antigen among acute and chronic hepatitis B virus infections in The Netherlands.荷兰急性和慢性乙型肝炎病毒感染者中乙型肝炎表面抗原的遗传变异。
J Med Virol. 2018 Oct;90(10):1576-1585. doi: 10.1002/jmv.25232. Epub 2018 Jun 7.